Latest News

Pharmac marks 12-month anniversary of funding boost July 25, 2025

Pharmac has marked one year since the Coalition announced a one-off NZ$604 million funding boost, confirming its subsequent decisions to fund 66 medicines that benefit nearly 250,000 New Zealanders.

FDA invites submissions to new rapid review priority program July 25, 2025

The US FDA has announced that companies can now submit to its new Commissioner’s National Priority Voucher program, which could see medicines reviewed and approved in one to two months.

AccessCR announces finalists in Consumer Partnerships in Research Awards July 24, 2025

AccessCR has announced the finalists in its inaugural national awards, celebrating the contributions made by patients, carers, and other users of services to health and medical research, and improving the lives of patients in the future.

Australian Life Sciences Venture Capital firm Brandon Capital announces Fund Six final close July 24, 2025

CSL, the Western Australian Government and Australia’s National Reconstruction Fund Corporation have joined others in investing a combined almost $439 million in Brandon Capital's Fund Six.

Australia on the list of countries to be targeted over pharmaceutical pricing July 24, 2025

Australia is thought to be one of a group of countries on a target list for special consideration regarding pharmaceutical pricing, as Republican Senators call for action through trade agreements.

Latest trade agreements reveal US focus on resolving longstanding issues July 24, 2025

The Trump administration's focus in these agreements has been resolving America's long-held grievances, which reveals what it might pursue in any negotiation with Australia.

Sanofi to acquire Vicebio, gaining rights to Queensland discovered technology July 23, 2025

Sanofi has agreed to acquire Vicebio, a privately held biotechnology company headquartered in London, which has rights to the Molecular Clamp Technology developed at the University of Queensland.

Senate Committee appointments reveal a significant shake-up July 23, 2025

Australia's parliament has returned this week following the May election, with the appointment of Senate committees revealing significant change.

OncoSil Medical completes recruitment in TRIPP-FFX clinical trial July 23, 2025

Pancreatic cancer treatment device company OncoSil Medical (ASX:OSL) has completed patient recruitment for the TRIPP-FFX clinical trial. The TRIPP-FFX study is a prospective, multicentre clinical...

Nyrada advances Xolatryp towards Phase 2a trial in cardioprotection July 23, 2025

Nyrada (ASX:NYR) has announced its intention to progress its candidate Xolatryp into a Phase 2a clinical trial for the treatment of acute myocardial infarction.

Amplia Therapeutics announces $25 million placement and launches share purchase plan July 23, 2025

Amplia Therapeutics (ASX:ATX) has successfully undertaken an institutional placement of $25 million in new, fully paid ordinary shares in the company at a price of $0.23 per share.

Percheron Therapeutics announces publication of new preclinical HMBD-002 data July 23, 2025

Percheron Therapeutics (ASX:PER) has shared new preclinical data for its investigational cancer drug, HMBD-002.

Latest Video

Most Read

Australia on the list of countries to be targeted over pharmaceutical pricing

Latest trade agreements reveal US focus on resolving longstanding issues

Senate Committee appointments reveal a significant shake-up

Pharmac marks 12-month anniversary of funding boost

FDA invites submissions to new rapid review priority program

New Stories

FDA invites submissions to new rapid review priority program

Pharmac marks 12-month anniversary of funding boost

AccessCR announces finalists in Consumer Partnerships in Research Awards

Australian Life Sciences Venture Capital firm Brandon Capital announces Fund Six final close

Australia on the list of countries to be targeted over pharmaceutical pricing

Latest trade agreements reveal US focus on resolving longstanding issues

Sanofi to acquire Vicebio, gaining rights to Queensland discovered technology

Sign In

Latest Video

Most Read

Australia on the list of countries to be targeted over pharmaceutical pricing

Latest trade agreements reveal US focus on resolving longstanding issues

Senate Committee appointments reveal a significant shake-up

Pharmac marks 12-month anniversary of funding boost

FDA invites submissions to new rapid review priority program

Follow Us

New Stories

FDA invites submissions to new rapid review priority program

Pharmac marks 12-month anniversary of funding boost

AccessCR announces finalists in Consumer Partnerships in Research Awards

Australian Life Sciences Venture Capital firm Brandon Capital announces Fund Six final close

Australia on the list of countries to be targeted over pharmaceutical pricing

Latest trade agreements reveal US focus on resolving longstanding issues

Sanofi to acquire Vicebio, gaining rights to Queensland discovered technology